| (1) | 
    Stanisstreet M, Herbert LC, Pharoah POD. Effects of thyroid antagonists 
      on rat embryos cultured in vitro. Teratology 1990; 41: 721-9. | 
  
   
    | (2) | 
    Momotani N, Ito K, Hamada N, et al. Maternal hyperthyroidism 
      and congenital malformation in the offspring. Clin Endocrinol 1984; 20: 
      695-700. | 
  
   
    | (3) | 
    Stanisstreet M, Pharoah POD, Herbert LC. Culture of rat embryos in sera 
      from human hyperthyroid subjects. Med Sci Res 1988; 16: 1105-6. | 
  
   
    | (4) | 
    Harakawa S, Akazawa S, Akazawa M, et al. Changes of serum thyroid hormone 
      levels induce malformations on early embryogenesis in rats. Acta Endocrinol 
      (Copenh) 1989; 121: 739-43. | 
  
   
    | (5) | 
    Sparre LS. Maternal free thyroxine and thyroxine-binding globulin during 
      pregnancy ending in congenital malformations in the offspring. Gynecol Obstet 
      Invest 1989; 27: 19-21. | 
  
   
    | (6) | 
    Glinoer D, Lemone M. Goiter and pregnancy: A new insight into and old 
      problem. Thyroid 1992; 2: 65-70. | 
  
   
    | (7) | 
    Gardner DF, Cruikshank DP, Hays PM, et al. Pharmacology of propylthiouracil 
      (PTU) in pregnant hyperthyroid women: correlation of matemal PTU concentrations 
      with cord serum thyroid function tests. J Clin Endocrinol Metab 1986; 62: 
      217-20. | 
  
   
    | (8) | 
    Momotani N, Noh J, Oyanagi H, et al. Antithyroid drug therapy for Graves' 
      disease during pregnancy. Optimal regimen for fetal thyroid status. N Engl 
      J Med 1986; 315: 24-8. | 
  
   
    | (9) | 
    Momotani N, Noh JY, Ishikawa N, et al. Effects of propylthiouracil and 
      methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism. 
      J Clin Endocrinol Metab 1997; 82: 3633-6. | 
  
   
    | (10) | 
    Dussault JH. Neonatal screening for congenital hypothyToidism. Clin Lab 
      Med 1993; 13: 645-52. | 
  
   
    | (11) | 
    Delange F. Neonatal screening for congenital hypothyroidism: results and 
      perspectives. Horrn Res 1997; 48: 51-61. | 
  
   
    | (12) | 
    McCaroll AM, Hutchinson M, McAuley R, et al. Long terrn assessment of 
      children exposed in utero to carbimazole. Arch Dis Child 1976; 51: 532-6. | 
  
   
    | (13) | 
    Burrow GN, Klatskin EH, Genel M. Intellectual development in children 
      whose mothers received propylt, hiouracil during pregnancy. Yale J Bio] 
      Med 1978; 51: 151-6. | 
  
   
    | (14) | 
    Messer PM, Hauffa BP, Olbricht T, et al. Antithyroid drug treatment of 
      Graves' disease in pregnancy: Iong-term effects on somatic growth, intellectual 
      development and thyroid function of the offspring. Acta Endocrinol (Copenh) 
      1990; 123: 311-6. | 
  
   
    | (15) | 
    Eisenstein Z, Weiss M, Katz Y, et al. Intellectual capacity of subjects 
      exposed to methimazole or propylthiouracil in utero. Eur J Pediatr 1992; 
      151: 558-9. | 
  
   
    | (16) | 
    Refetoff S, Ochi Y, Selenkow HA, et aL Neonat.al hypothyroidism and goiter 
      in one infant of each of two sets of twins due to meternal therapy with 
      antithyroid drugs. J Pediatr 1974; 85: 240-4. | 
  
   
    | (17) | 
    Robinson PL, O'Mullane NH, Aldernam B. Pr'e_na. tal t, rea.tment of fetal 
      t.hyrotoxicosis. BMJ 1979; 1: 383-4. | 
  
   
    | (18) | 
    Cove DH, Johnston P. Fetal hyperthyroidism. Experience of treatment in 
      four siblings. Lancet 1985; 1: 430-2. | 
  
   
    | (19) | 
    Momotani N, Hisaoka T, Noh J, et al. Effects of io. dine on thyroid status 
      of fetus versus mot,her in treatment of Graves' disease complicated by pregnancy. 
      J Clin Endocrinol Metab 1992; 75: 738-44. |